Home » Merck nears $6bn biotech deal to boost cancer drug pipeline
FinancIal Times

Merck nears $6bn biotech deal to boost cancer drug pipeline

by External Source

Terns Pharma stock has jumped since promising clinical data on its bone and blood cancer treatment last yearOriginal Article

Africa News Matters is powered by the Colorado non-profit Africa Agenda. We credit our sources via link sharing. Support us, make a donation today!

You may also like

Quant funds rocked as Treasury boosts buybacks and...

Stripe bets that an AI world still needs...

Brazilian municipalities join BHP and Vale dam collapse...

Today’s China could learn from Jiang and Zhu

The US Treasury is buying long bonds, but...

Nvidia looks well placed to benefit from the...

US long-term bonds slide as Bessent intervention fails...

Trump’s South Korea defence flip reminds Japan that...

Moderna breakthrough brings back memories of pandemic mania

America’s national debt hits record $40tn

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
@2026 Africa Agenda. All Rights Reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More